Jong Bok Lee

Venetoclax enhances T cell–mediated antileukemic activity by increasing ROS production

Jong Bok Lee, Dilshad H. Khan, Rose Hurren et al. · Blood · 2021 · 145 citations · Full text

Life Sciences, Immunology, Pharmacology +16

Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms

Jong Bok Lee, Mark D. Minden, Weihsu C. Chen et al. · Clinical Cancer Research · 2017 · 106 citations · Full text

Medicine, Hematology, Immunology +17

Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15

Junlin Yao, Dalam Ly, Dzana Dervovic et al. · Journal for ImmunoTherapy of Cancer · 2019 · 81 citations · Full text

Medicine, Immunology, Oncology +17

Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade

Linan Fang, Dalam Ly, Sisi Wang et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 68 citations · Full text

Medicine, Immunology, Oncology +17

Allogeneic double-negative CAR-T cells inhibit tumor growth without off-tumor toxicities

Daniel Vasić, Jong Bok Lee, Y.K. Leung et al. · Science Immunology · 2022 · 68 citations

Medicine, Immunology, Oncology +17